MedTrace Logo

A Multi-center, International Prospective Follow up Study

NCT04579913 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2021-04-29

No results posted yet for this study

Summary

The study objective is to assess the safety and efficacy of iTind three to five years following treatment.

Conditions

  • Benign Prostatic Hyperplasia (BPH)

Interventions

OTHER

Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound

Administration of questionnaires to assess patient LUTS, quality of life, sexual behavior and erectile function, in addition to performing PVR and uroflow tests.

Sponsors & Collaborators

  • Medi-Tate Ltd.

    lead INDUSTRY

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-21
Primary Completion
2021-03-12
Completion
2021-04-22

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579913 on ClinicalTrials.gov